pubmed-article:2482891 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2482891 | lifeskim:mentions | umls-concept:C0009325 | lld:lifeskim |
pubmed-article:2482891 | lifeskim:mentions | umls-concept:C0034069 | lld:lifeskim |
pubmed-article:2482891 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:2482891 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
pubmed-article:2482891 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:2482891 | pubmed:dateCreated | 1990-3-20 | lld:pubmed |
pubmed-article:2482891 | pubmed:abstractText | Collagen cross-linking was analyzed in lungs of rats, two, four, and ten weeks after intratracheal instillation of 1.5 units of bleomycin. Similar analyses were performed on lungs of mice 18 months after intratracheal instillation of bleomycin with or without subsequent exposure to 70% oxygen (O2) for 72 hours. Lungs were analyzed to determine the content of the reduced difunctional cross-links dihydroxylysinonorleucine (DHLNL) and hydroxylysinonorleucine (HLNL) and of the nonreducible trifunctional cross-link hydroxypyridinium (OHP). Ratios of DHLNL:HLNL were elevated in the rat lungs at two and four weeks, due to increased levels of DHLNL. There were no changes in the difunctional cross-links in any of the mouse lungs. Hydroxypyridinium content was elevated in the rat lungs at ten weeks and in the mouse lungs exposed to bleomycin and oxygen. We conclude that increases in DHLNL may serve as an early indicator that potentially "fibrotic collagen" is being synthesized in lungs acutely exposed to fibrogenic stimuli, while increases in OHP may serve as a permanent marker of a fibrogenic event that could have occurred months to years earlier. | lld:pubmed |
pubmed-article:2482891 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:language | eng | lld:pubmed |
pubmed-article:2482891 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2482891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2482891 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2482891 | pubmed:month | Mar | lld:pubmed |
pubmed-article:2482891 | pubmed:issn | 0887-2082 | lld:pubmed |
pubmed-article:2482891 | pubmed:author | pubmed-author:LastJ AJA | lld:pubmed |
pubmed-article:2482891 | pubmed:author | pubmed-author:ReiserK MKM | lld:pubmed |
pubmed-article:2482891 | pubmed:author | pubmed-author:TrykaA FAF | lld:pubmed |
pubmed-article:2482891 | pubmed:author | pubmed-author:Lindenschmidt... | lld:pubmed |
pubmed-article:2482891 | pubmed:author | pubmed-author:WitschiH RHR | lld:pubmed |
pubmed-article:2482891 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2482891 | pubmed:volume | 1 | lld:pubmed |
pubmed-article:2482891 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2482891 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2482891 | pubmed:pagination | 83-91 | lld:pubmed |
pubmed-article:2482891 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:meshHeading | pubmed-meshheading:2482891-... | lld:pubmed |
pubmed-article:2482891 | pubmed:year | 1986 | lld:pubmed |
pubmed-article:2482891 | pubmed:articleTitle | Changes in collagen cross-linking in bleomycin-induced pulmonary fibrosis. | lld:pubmed |
pubmed-article:2482891 | pubmed:affiliation | Department of Internal Medicine, School of Medicine, University of California, Davis. | lld:pubmed |
pubmed-article:2482891 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2482891 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2482891 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2482891 | lld:pubmed |